Open-Label Extension of Other SZ1839 (Iressa) Trials

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ)

NCT01867996 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)

NCT03867318 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Drug-Drug Interactions of Obicetrapib Tablets and Ezetimibe Tablets in Healthy Adult Subjects

NCT06547359 ·Status: COMPLETED ·Phase: PHASE1

A Trial of DDI Between SHR1459 and Efavirenz With Healthy Subjects

NCT05560360 ·Status: COMPLETED ·Phase: PHASE1

Effect of Ezetimibe Treatment on Low-density Lipoprotein Cholesterol (LDL-C) Levels in Participants With Coronary Heart Disease (CHD) Already Treated With a Statin (MK-0653A-205 AM1)

NCT01381679 ·Status: COMPLETED

Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects

NCT05681247 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment

NCT00162097 ·Status: COMPLETED ·Phase: PHASE1

Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen

NCT00018083 ·Status: UNKNOWN ·Phase: NA

GSK1349572 Drug Interaction Study With Efavirenz

NCT01098526 ·Status: COMPLETED ·Phase: PHASE1

Ezetrol Post-Marketing Study

NCT00753883 ·Status: COMPLETED ·Phase: PHASE4

TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)

NCT00328523 ·Status: COMPLETED ·Phase: PHASE3

Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets

NCT00908011 ·Status: COMPLETED ·Phase: NA

Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2

NCT00810303 ·Status: COMPLETED ·Phase: PHASE1

Regeneron 1331 Kinetics Sub-Study HoFH

NCT04722068 ·Status: COMPLETED ·Phase: NA

The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream

NCT01836198 ·Status: COMPLETED ·Phase: PHASE1

A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)

NCT00652301 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects

NCT00621101 ·Status: COMPLETED ·Phase: PHASE1

Effect of Repeated Administration of Eslicarbazepine Acetate on the Pharmacokinetics of Simvastatin in Healthy Subjects

NCT00987558 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Participants

NCT04459598 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men

NCT02138799 ·Status: COMPLETED ·Phase: PHASE1

Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV

NCT04820933 ·Status: COMPLETED ·Phase: EARLY_PHASE1

MD Ezetimibe Cyclosporine Interaction (0653-057)

NCT00653276 ·Status: COMPLETED ·Phase: PHASE1

The PostprAndial eNdothelial Function After Combination of Ezetimibe and simvAstatin Study

NCT00817843 ·Status: COMPLETED ·Phase: PHASE4

Drug-Drug Interaction of Pyrotinib With a Moderate CYP3A Inducer

NCT04680091 ·Status: UNKNOWN ·Phase: PHASE1

Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults

NCT00099684 ·Status: COMPLETED ·Phase: NA